Global Gene Therapy Market Growth (Status and Outlook) 2025-2031
According to this study, the global Gene Therapy market size will reach US$ 63520 million by 2031.
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
LPI (LP Information)' newest research report, the “Gene Therapy Industry Forecast” looks at past sales and reviews total world Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy sales for 2025 through 2031. With Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
The Gene Therapy market is driven by the growing demand for innovative treatments for rare genetic disorders, cancers, and chronic diseases that lack effective conventional therapies. Advancements in gene editing technologies such as CRISPR/Cas9, improved viral and non-viral delivery vectors, and increasing knowledge of the human genome have made gene therapy a promising option in precision medicine. Regulatory agencies are also offering accelerated approval pathways for breakthrough gene therapies, encouraging investment and speeding up clinical development. In addition, rising public and private funding, along with successful commercialization of landmark therapies like Zolgensma and Luxturna, are fueling confidence and expansion in this market.
Despite its potential, the Gene Therapy market faces several critical challenges, including high development and treatment costs, complex manufacturing processes, and safety concerns. Producing gene therapies requires highly specialized facilities and stringent quality control, leading to limited scalability and high prices, which can exceed millions of dollars per patient. Furthermore, long-term safety data are still lacking, with concerns over immune responses, off-target effects, and durability of treatment outcomes. Regulatory, ethical, and reimbursement hurdles also pose significant barriers to broader adoption. Addressing these challenges is essential to ensure accessibility, affordability, and the long-term success of gene therapy as a mainstream medical solution.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent. In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
LPI (LP Information)' newest research report, the “Gene Therapy Industry Forecast” looks at past sales and reviews total world Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected Gene Therapy sales for 2025 through 2031. With Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Therapy industry.
This Insight Report provides a comprehensive analysis of the global Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Therapy.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Viral Gene Therapy
- Non-Viral Gene Therapy
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Roche
- Akcea Therapeutics
- bluebird bio
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
- CSL Behring
- BioMarin Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy Market Size (2020-2031)
2.1.2 Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-Viral Gene Therapy
2.3 Gene Therapy Market Size by Type
2.3.1 Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene Therapy Market Size by Application
2.5.1 Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy Market Size Market Share by Application (2020-2025)
3 GENE THERAPY MARKET SIZE BY PLAYER
3.1 Gene Therapy Market Size Market Share by Player
3.1.1 Global Gene Therapy Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY BY REGION
4.1 Gene Therapy Market Size by Region (2020-2025)
4.2 Global Gene Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy Market Size Growth (2020-2025)
4.4 APAC Gene Therapy Market Size Growth (2020-2025)
4.5 Europe Gene Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy Market Size by Country (2020-2025)
5.2 Americas Gene Therapy Market Size by Type (2020-2025)
5.3 Americas Gene Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Market Size by Region (2020-2025)
6.2 APAC Gene Therapy Market Size by Type (2020-2025)
6.3 APAC Gene Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy Market Size by Country (2020-2025)
7.2 Europe Gene Therapy Market Size by Type (2020-2025)
7.3 Europe Gene Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY MARKET FORECAST
10.1 Global Gene Therapy Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy Forecast
10.1.3 APAC Gene Therapy Forecast
10.1.4 Europe Gene Therapy Forecast
10.1.5 Middle East & Africa Gene Therapy Forecast
10.2 Americas Gene Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy Forecast
10.2.2 Canada Market Gene Therapy Forecast
10.2.3 Mexico Market Gene Therapy Forecast
10.2.4 Brazil Market Gene Therapy Forecast
10.3 APAC Gene Therapy Forecast by Region (2026-2031)
10.3.1 China Gene Therapy Market Forecast
10.3.2 Japan Market Gene Therapy Forecast
10.3.3 Korea Market Gene Therapy Forecast
10.3.4 Southeast Asia Market Gene Therapy Forecast
10.3.5 India Market Gene Therapy Forecast
10.3.6 Australia Market Gene Therapy Forecast
10.4 Europe Gene Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy Forecast
10.4.2 France Market Gene Therapy Forecast
10.4.3 UK Market Gene Therapy Forecast
10.4.4 Italy Market Gene Therapy Forecast
10.4.5 Russia Market Gene Therapy Forecast
10.5 Middle East & Africa Gene Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy Forecast
10.5.2 South Africa Market Gene Therapy Forecast
10.5.3 Israel Market Gene Therapy Forecast
10.5.4 Turkey Market Gene Therapy Forecast
10.6 Global Gene Therapy Forecast by Type (2026-2031)
10.7 Global Gene Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy Product Offered
11.1.3 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy Product Offered
11.2.3 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy Product Offered
11.3.3 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy Product Offered
11.6.3 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Gene Therapy Product Offered
11.7.3 Roche Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy Product Offered
11.9.3 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy Product Offered
11.10.3 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy Product Offered
11.11.3 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy Product Offered
11.12.3 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
11.15 CSL Behring
11.15.1 CSL Behring Company Information
11.15.2 CSL Behring Gene Therapy Product Offered
11.15.3 CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 CSL Behring Main Business Overview
11.15.5 CSL Behring Latest Developments
11.16 BioMarin Pharmaceutical
11.16.1 BioMarin Pharmaceutical Company Information
11.16.2 BioMarin Pharmaceutical Gene Therapy Product Offered
11.16.3 BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 BioMarin Pharmaceutical Main Business Overview
11.16.5 BioMarin Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene Therapy Market Size (2020-2031)
2.1.2 Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Gene Therapy by Country/Region (2020, 2024 & 2031)
2.2 Gene Therapy Segment by Type
2.2.1 Viral Gene Therapy
2.2.2 Non-Viral Gene Therapy
2.3 Gene Therapy Market Size by Type
2.3.1 Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Gene Therapy Market Size Market Share by Type (2020-2025)
2.4 Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene Therapy Market Size by Application
2.5.1 Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Gene Therapy Market Size Market Share by Application (2020-2025)
3 GENE THERAPY MARKET SIZE BY PLAYER
3.1 Gene Therapy Market Size Market Share by Player
3.1.1 Global Gene Therapy Revenue by Player (2020-2025)
3.1.2 Global Gene Therapy Revenue Market Share by Player (2020-2025)
3.2 Global Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE THERAPY BY REGION
4.1 Gene Therapy Market Size by Region (2020-2025)
4.2 Global Gene Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gene Therapy Market Size Growth (2020-2025)
4.4 APAC Gene Therapy Market Size Growth (2020-2025)
4.5 Europe Gene Therapy Market Size Growth (2020-2025)
4.6 Middle East & Africa Gene Therapy Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Gene Therapy Market Size by Country (2020-2025)
5.2 Americas Gene Therapy Market Size by Type (2020-2025)
5.3 Americas Gene Therapy Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene Therapy Market Size by Region (2020-2025)
6.2 APAC Gene Therapy Market Size by Type (2020-2025)
6.3 APAC Gene Therapy Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene Therapy Market Size by Country (2020-2025)
7.2 Europe Gene Therapy Market Size by Type (2020-2025)
7.3 Europe Gene Therapy Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene Therapy by Region (2020-2025)
8.2 Middle East & Africa Gene Therapy Market Size by Type (2020-2025)
8.3 Middle East & Africa Gene Therapy Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE THERAPY MARKET FORECAST
10.1 Global Gene Therapy Forecast by Region (2026-2031)
10.1.1 Global Gene Therapy Forecast by Region (2026-2031)
10.1.2 Americas Gene Therapy Forecast
10.1.3 APAC Gene Therapy Forecast
10.1.4 Europe Gene Therapy Forecast
10.1.5 Middle East & Africa Gene Therapy Forecast
10.2 Americas Gene Therapy Forecast by Country (2026-2031)
10.2.1 United States Market Gene Therapy Forecast
10.2.2 Canada Market Gene Therapy Forecast
10.2.3 Mexico Market Gene Therapy Forecast
10.2.4 Brazil Market Gene Therapy Forecast
10.3 APAC Gene Therapy Forecast by Region (2026-2031)
10.3.1 China Gene Therapy Market Forecast
10.3.2 Japan Market Gene Therapy Forecast
10.3.3 Korea Market Gene Therapy Forecast
10.3.4 Southeast Asia Market Gene Therapy Forecast
10.3.5 India Market Gene Therapy Forecast
10.3.6 Australia Market Gene Therapy Forecast
10.4 Europe Gene Therapy Forecast by Country (2026-2031)
10.4.1 Germany Market Gene Therapy Forecast
10.4.2 France Market Gene Therapy Forecast
10.4.3 UK Market Gene Therapy Forecast
10.4.4 Italy Market Gene Therapy Forecast
10.4.5 Russia Market Gene Therapy Forecast
10.5 Middle East & Africa Gene Therapy Forecast by Region (2026-2031)
10.5.1 Egypt Market Gene Therapy Forecast
10.5.2 South Africa Market Gene Therapy Forecast
10.5.3 Israel Market Gene Therapy Forecast
10.5.4 Turkey Market Gene Therapy Forecast
10.6 Global Gene Therapy Forecast by Type (2026-2031)
10.7 Global Gene Therapy Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Gene Therapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene Therapy Product Offered
11.1.3 Biogen Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene Therapy Product Offered
11.2.3 Novartis Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene Therapy Product Offered
11.3.3 Gilead Sciences Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene Therapy Product Offered
11.6.3 Amgen Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Gene Therapy Product Offered
11.7.3 Roche Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 bluebird bio
11.9.1 bluebird bio Company Information
11.9.2 bluebird bio Gene Therapy Product Offered
11.9.3 bluebird bio Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 bluebird bio Main Business Overview
11.9.5 bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Gene Therapy Product Offered
11.10.3 Sunway Biotech Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Gene Therapy Product Offered
11.11.3 SIBIONO Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Gene Therapy Product Offered
11.12.3 AnGes Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
11.15 CSL Behring
11.15.1 CSL Behring Company Information
11.15.2 CSL Behring Gene Therapy Product Offered
11.15.3 CSL Behring Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 CSL Behring Main Business Overview
11.15.5 CSL Behring Latest Developments
11.16 BioMarin Pharmaceutical
11.16.1 BioMarin Pharmaceutical Company Information
11.16.2 BioMarin Pharmaceutical Gene Therapy Product Offered
11.16.3 BioMarin Pharmaceutical Gene Therapy Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 BioMarin Pharmaceutical Main Business Overview
11.16.5 BioMarin Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-Viral Gene Therapy
Table 5. Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy Key Players Head office and Products Offered
Table 14. Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy
Table 39. Key Market Challenges & Risks of Gene Therapy
Table 40. Key Industry Trends of Gene Therapy
Table 41. Global Gene Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Biogen Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 46. Biogen Gene Therapy Product Offered
Table 47. Biogen Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Biogen Main Business
Table 49. Biogen Latest Developments
Table 50. Novartis Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 51. Novartis Gene Therapy Product Offered
Table 52. Novartis Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Gilead Sciences Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 56. Gilead Sciences Gene Therapy Product Offered
Table 57. Gilead Sciences Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Latest Developments
Table 60. Sarepta Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 61. Sarepta Therapeutics Gene Therapy Product Offered
Table 62. Sarepta Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Latest Developments
Table 65. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 66. Alnylam Pharmaceuticals Gene Therapy Product Offered
Table 67. Alnylam Pharmaceuticals Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Alnylam Pharmaceuticals Main Business
Table 69. Alnylam Pharmaceuticals Latest Developments
Table 70. Amgen Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 71. Amgen Gene Therapy Product Offered
Table 72. Amgen Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Amgen Main Business
Table 74. Amgen Latest Developments
Table 75. Roche Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 76. Roche Gene Therapy Product Offered
Table 77. Roche Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Akcea Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 81. Akcea Therapeutics Gene Therapy Product Offered
Table 82. Akcea Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Akcea Therapeutics Main Business
Table 84. Akcea Therapeutics Latest Developments
Table 85. bluebird bio Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 86. bluebird bio Gene Therapy Product Offered
Table 87. bluebird bio Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. bluebird bio Main Business
Table 89. bluebird bio Latest Developments
Table 90. Sunway Biotech Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 91. Sunway Biotech Gene Therapy Product Offered
Table 92. Sunway Biotech Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Latest Developments
Table 95. SIBIONO Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 96. SIBIONO Gene Therapy Product Offered
Table 97. SIBIONO Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. SIBIONO Main Business
Table 99. SIBIONO Latest Developments
Table 100. AnGes Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 101. AnGes Gene Therapy Product Offered
Table 102. AnGes Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. AnGes Main Business
Table 104. AnGes Latest Developments
Table 105. Orchard Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 106. Orchard Therapeutics Gene Therapy Product Offered
Table 107. Orchard Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Latest Developments
Table 110. Human Stem Cells Institute Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 111. Human Stem Cells Institute Gene Therapy Product Offered
Table 112. Human Stem Cells Institute Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Latest Developments
Table 115. CSL Behring Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 116. CSL Behring Gene Therapy Product Offered
Table 117. CSL Behring Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. CSL Behring Main Business
Table 119. CSL Behring Latest Developments
Table 120. BioMarin Pharmaceutical Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 121. BioMarin Pharmaceutical Gene Therapy Product Offered
Table 122. BioMarin Pharmaceutical Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. BioMarin Pharmaceutical Main Business
Table 124. BioMarin Pharmaceutical Latest Developments
Table 1. Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Gene Therapy Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Viral Gene Therapy
Table 4. Major Players of Non-Viral Gene Therapy
Table 5. Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Gene Therapy Market Size Market Share by Type (2020-2025)
Table 8. Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Gene Therapy Market Size Market Share by Application (2020-2025)
Table 11. Global Gene Therapy Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Gene Therapy Revenue Market Share by Player (2020-2025)
Table 13. Gene Therapy Key Players Head office and Products Offered
Table 14. Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Table 19. Global Gene Therapy Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Gene Therapy Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Gene Therapy Market Size Market Share by Country (2020-2025)
Table 23. Americas Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Gene Therapy Market Size Market Share by Type (2020-2025)
Table 25. Americas Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Gene Therapy Market Size Market Share by Application (2020-2025)
Table 27. APAC Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Gene Therapy Market Size Market Share by Region (2020-2025)
Table 29. APAC Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Gene Therapy Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Gene Therapy Market Size Market Share by Country (2020-2025)
Table 33. Europe Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Gene Therapy Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Gene Therapy Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Gene Therapy Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Gene Therapy
Table 39. Key Market Challenges & Risks of Gene Therapy
Table 40. Key Industry Trends of Gene Therapy
Table 41. Global Gene Therapy Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Gene Therapy Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Gene Therapy Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Gene Therapy Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Biogen Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 46. Biogen Gene Therapy Product Offered
Table 47. Biogen Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Biogen Main Business
Table 49. Biogen Latest Developments
Table 50. Novartis Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 51. Novartis Gene Therapy Product Offered
Table 52. Novartis Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Novartis Main Business
Table 54. Novartis Latest Developments
Table 55. Gilead Sciences Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 56. Gilead Sciences Gene Therapy Product Offered
Table 57. Gilead Sciences Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences Latest Developments
Table 60. Sarepta Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 61. Sarepta Therapeutics Gene Therapy Product Offered
Table 62. Sarepta Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Sarepta Therapeutics Main Business
Table 64. Sarepta Therapeutics Latest Developments
Table 65. Alnylam Pharmaceuticals Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 66. Alnylam Pharmaceuticals Gene Therapy Product Offered
Table 67. Alnylam Pharmaceuticals Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Alnylam Pharmaceuticals Main Business
Table 69. Alnylam Pharmaceuticals Latest Developments
Table 70. Amgen Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 71. Amgen Gene Therapy Product Offered
Table 72. Amgen Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Amgen Main Business
Table 74. Amgen Latest Developments
Table 75. Roche Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 76. Roche Gene Therapy Product Offered
Table 77. Roche Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Roche Main Business
Table 79. Roche Latest Developments
Table 80. Akcea Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 81. Akcea Therapeutics Gene Therapy Product Offered
Table 82. Akcea Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Akcea Therapeutics Main Business
Table 84. Akcea Therapeutics Latest Developments
Table 85. bluebird bio Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 86. bluebird bio Gene Therapy Product Offered
Table 87. bluebird bio Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. bluebird bio Main Business
Table 89. bluebird bio Latest Developments
Table 90. Sunway Biotech Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 91. Sunway Biotech Gene Therapy Product Offered
Table 92. Sunway Biotech Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Latest Developments
Table 95. SIBIONO Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 96. SIBIONO Gene Therapy Product Offered
Table 97. SIBIONO Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. SIBIONO Main Business
Table 99. SIBIONO Latest Developments
Table 100. AnGes Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 101. AnGes Gene Therapy Product Offered
Table 102. AnGes Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. AnGes Main Business
Table 104. AnGes Latest Developments
Table 105. Orchard Therapeutics Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 106. Orchard Therapeutics Gene Therapy Product Offered
Table 107. Orchard Therapeutics Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Latest Developments
Table 110. Human Stem Cells Institute Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 111. Human Stem Cells Institute Gene Therapy Product Offered
Table 112. Human Stem Cells Institute Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Latest Developments
Table 115. CSL Behring Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 116. CSL Behring Gene Therapy Product Offered
Table 117. CSL Behring Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 118. CSL Behring Main Business
Table 119. CSL Behring Latest Developments
Table 120. BioMarin Pharmaceutical Details, Company Type, Gene Therapy Area Served and Its Competitors
Table 121. BioMarin Pharmaceutical Gene Therapy Product Offered
Table 122. BioMarin Pharmaceutical Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 123. BioMarin Pharmaceutical Main Business
Table 124. BioMarin Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy Market Size Market Share by Type in 2024
Figure 10. Gene Therapy in Neurological Diseases
Figure 11. Global Gene Therapy Market: Neurological Diseases (2020-2025) & ($ millions)
Figure 12. Gene Therapy in Cancer
Figure 13. Global Gene Therapy Market: Cancer (2020-2025) & ($ millions)
Figure 14. Gene Therapy in Other
Figure 15. Global Gene Therapy Market: Other (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy Value Market Share by Country in 2024
Figure 24. United States Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy Market Size 2026-2031 ($ millions)
Figure 1. Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene Therapy Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Gene Therapy Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Gene Therapy Sales Market Share by Country/Region (2024)
Figure 8. Gene Therapy Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Gene Therapy Market Size Market Share by Type in 2024
Figure 10. Gene Therapy in Neurological Diseases
Figure 11. Global Gene Therapy Market: Neurological Diseases (2020-2025) & ($ millions)
Figure 12. Gene Therapy in Cancer
Figure 13. Global Gene Therapy Market: Cancer (2020-2025) & ($ millions)
Figure 14. Gene Therapy in Other
Figure 15. Global Gene Therapy Market: Other (2020-2025) & ($ millions)
Figure 16. Global Gene Therapy Market Size Market Share by Application in 2024
Figure 17. Global Gene Therapy Revenue Market Share by Player in 2024
Figure 18. Global Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 19. Americas Gene Therapy Market Size 2020-2025 ($ millions)
Figure 20. APAC Gene Therapy Market Size 2020-2025 ($ millions)
Figure 21. Europe Gene Therapy Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Gene Therapy Market Size 2020-2025 ($ millions)
Figure 23. Americas Gene Therapy Value Market Share by Country in 2024
Figure 24. United States Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Gene Therapy Market Size Market Share by Region in 2024
Figure 29. APAC Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 30. APAC Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 31. China Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 35. India Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Gene Therapy Market Size Market Share by Country in 2024
Figure 38. Europe Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 39. Europe Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 40. Germany Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 41. France Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Gene Therapy Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Gene Therapy Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Gene Therapy Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Gene Therapy Market Size 2026-2031 ($ millions)
Figure 54. APAC Gene Therapy Market Size 2026-2031 ($ millions)
Figure 55. Europe Gene Therapy Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Gene Therapy Market Size 2026-2031 ($ millions)
Figure 57. United States Gene Therapy Market Size 2026-2031 ($ millions)
Figure 58. Canada Gene Therapy Market Size 2026-2031 ($ millions)
Figure 59. Mexico Gene Therapy Market Size 2026-2031 ($ millions)
Figure 60. Brazil Gene Therapy Market Size 2026-2031 ($ millions)
Figure 61. China Gene Therapy Market Size 2026-2031 ($ millions)
Figure 62. Japan Gene Therapy Market Size 2026-2031 ($ millions)
Figure 63. Korea Gene Therapy Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 65. India Gene Therapy Market Size 2026-2031 ($ millions)
Figure 66. Australia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 67. Germany Gene Therapy Market Size 2026-2031 ($ millions)
Figure 68. France Gene Therapy Market Size 2026-2031 ($ millions)
Figure 69. UK Gene Therapy Market Size 2026-2031 ($ millions)
Figure 70. Italy Gene Therapy Market Size 2026-2031 ($ millions)
Figure 71. Russia Gene Therapy Market Size 2026-2031 ($ millions)
Figure 72. Egypt Gene Therapy Market Size 2026-2031 ($ millions)
Figure 73. South Africa Gene Therapy Market Size 2026-2031 ($ millions)
Figure 74. Israel Gene Therapy Market Size 2026-2031 ($ millions)
Figure 75. Turkey Gene Therapy Market Size 2026-2031 ($ millions)
Figure 76. Global Gene Therapy Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Gene Therapy Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Gene Therapy Market Size 2026-2031 ($ millions)
